BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4566564)

  • 1. Fluspirilene, an injectable, and penfluridol, an oral long-acting, neuroleptic. A comparative double-blind trial in residual schizophrenia.
    Tanghe A; Vereecken JL
    Acta Psychiatr Scand; 1972; 48(4):315-31. PubMed ID: 4566564
    [No Abstract]   [Full Text] [Related]  

  • 2. Penfluridol (R 16341). A long-acting oral neuroleptic, as maintenance therapy for schizophrenic and mentally retarded patients. A placebo-controlled double-blind trial.
    Zwanikken GJ
    Psychiatr Neurol Neurochir; 1973; 76(2):83-92. PubMed ID: 4573494
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.
    Vandecasteele AJ; Vereecken JL
    Acta Psychiatr Scand; 1974; 50(3):346-53. PubMed ID: 4609288
    [No Abstract]   [Full Text] [Related]  

  • 4. Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.
    Jus A; Pineau R; Jus K; Villeneuve A; Gautier J; Pires P; Drolet A; Cote M; Villeneuve R
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1041-58. PubMed ID: 4215617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 6. Penfluridol: an efficacious long-acting oral antipsychotic compound.
    Gallant DM; Mielke DH; Spirtes MA; Swanson WC; Bost R
    Am J Psychiatry; 1974 Jun; 131(6):699-702. PubMed ID: 4597305
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluspirilene, a long-acting injectable neuroleptic.
    Ciccarelli G; Nosé F; Zuanazzi GF
    Acta Psychiatr Belg; 1972 Nov; 72(6):736-47. PubMed ID: 4679675
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical evaluation of fluspirilene as a maintenance therapy in chronic schizophrenic patients.
    Singh AN
    Can Psychiatr Assoc J; 1973 Oct; 18(5):415-9. PubMed ID: 4746145
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
    White AC; Sims AC
    Curr Med Res Opin; 1974; 2(1):23-6. PubMed ID: 4841811
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A; Vereecken JL
    Psychiatr Neurol Neurochir; 1971; 74(5):379-89. PubMed ID: 5138128
    [No Abstract]   [Full Text] [Related]  

  • 11. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J; Frei M; Scharfetter Chr
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of the long-acting injectable neuroleptic, fluspirilene, in the treatment of schizophrenic and mentally retarded patients.
    Zwanikken GJ; Remans B; Dewulf P; Amery W
    Acta Psychiatr Scand; 1971; 47(3):334-48. PubMed ID: 4946910
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K; Fullerton AG; Hussain K; Tarlo L
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of neuroleptics in the treatment of dementia in old age. A critical analysis with reference to an experiment with a long-acting oral neuroleptic (penfluridol Janssen).
    Cahn LA; Diesfeldt HF
    Psychiatr Neurol Neurochir; 1973; 76(6):411-20. PubMed ID: 4592700
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.
    Ota KY; Kurland AA; Slotnick VB
    J Clin Pharmacol; 1974 Apr; 14(4):202-9. PubMed ID: 4595986
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia.
    Vereecken JL; Tanghe A
    Psychiatr Neurol Neurochir; 1972; 75(2):117-27. PubMed ID: 5030483
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of piperacetazine (Quide) injection in acute schizophrenics.
    Kiev A; Güclü B; Kulkarni AS
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):376-80. PubMed ID: 4625517
    [No Abstract]   [Full Text] [Related]  

  • 18. Peroral and parenteral administration of long-acting neuroleptics: a double-blind study of penfluridol compared to flupenthixol decanoate in the treatment of schizophrenia.
    Gerlach J; Kramp P; Kristjansen P; Lauritsen B; Lühdorf K; Munkvad I
    Acta Psychiatr Scand; 1975 Aug; 52(2):132-44. PubMed ID: 1096541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long term neuroleptic therapy using fluspirilene and penfluridol].
    Haase HJ; Fischer D; Floru L; Frank T; Joseph K; Knaack M; Mohr W; Richter-Peill H; Steuer A; Wahl G; Walterbusch G; Zurborn R
    Nervenarzt; 1971 Dec; 42(12):632-7. PubMed ID: 5134761
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current status of neuroleptic long term treatment of schizophrenia].
    Woggon B; Angst J; Margoses N
    Nervenarzt; 1975 Nov; 46(11):611-6. PubMed ID: 813157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.